BDO USA acquired BioProcess Technology Consultants, a provider of chemistry, manufacturing and controls (CMC) consulting services to the global biopharmaceutical industry.
The acquisition of BioProcess bolsters BDO’s capabilities in the life sciences industry within the biopharmaceutical product development space.
“Joining forces with BioProcess strengthens our ability to assist life sciences companies in managing risk, maximizing profitability and fostering continued innovation to unlock new value and deliver improved outcomes,” Eric Jia-Sobota, national leader of BDO’s industry specialty services and life sciences practices, said in a statement.
Howard Levine, founder, president and CEO of BioProcess, will become managing director and national leader of the Bioprocess Technology Group within BDO’s life sciences practice.
“Since our inception, we’ve worked with companies to advance and de-risk the biotherapeutic development process, address unmet medical needs and increase patient access to novel medicines,” Mr. Levine said.
